Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Terminated Initiated Jun 16, 2020 (6 years ago)

Heparin Sodium 5

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Subpotent Drug: Out-of-Specification potency results at the 30-day stability timepoint.

Cause type: Wrong potency / content

Sub- or super-potent product, or a failed content-uniformity / assay test. You may receive too little or too much active ingredient - a direct dosing risk. All wrong potency / content recalls.

What was recalled

Heparin Sodium 5,000 units in 0.9% Sodium Chloride 1000 mL bag (5 units/mL), Rx Only, SCA Pharmaceuticals 755 Rainbow Rd. Windsor, CT 06095, NDC 70004-0650-46

Affected NDC 70004-0650-46

Compare with the code on your package — it is the most precise check available.

Drug: Heparin

Recalling firm
SCA Pharmaceuticals
NDC code
70004-0650-46
Origin
CT, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1311-2020 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Heparin recalls

See all

Other recalls by SCA Pharmaceuticals

All 2020 recalls